Zobrazeno 1 - 10
of 288
pro vyhledávání: '"rapid virological response"'
Autor:
Sung Yong Han, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Sung Ik Pyeon, Young Joo Park, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 3, Pp 544-556 (2021)
Background/Aims Real-world, clinical practice data are lacking about sofosbuvir/ribavirin (SOF/RBV) treatment of Korean patients with hepatitis C virus genotype 2 (HCV GT2) infection. This study investigated the efficacy and safety of SOF/RBV in Kore
Externí odkaz:
https://doaj.org/article/0dd5b4717f3944f68bcf0a17c19e2477
Autor:
Borba HHL, Wiens A, Steimbach LM, Tonin FS, Pedroso MLA, Ivantes CAP, Fernandez-Llimos F, Pontarolo R
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 13, Pp 59-64 (2017)
Helena HL Borba,1 Astrid Wiens,1 Laiza M Steimbach,1 Fernanda S Tonin,1 Maria LA Pedroso,2 Cláudia AP Ivantes,3 Fernando Fernandez-Llimos,4 Roberto Pontarolo1 1Pharmaceutical Sciences Postgraduate Research Program, Department of Pharmacy, 2Gastroent
Externí odkaz:
https://doaj.org/article/13a265fa6f644c1e814f01ac687e614c
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 32, Iss 7, Pp 381-386 (2016)
The lower limits of virus detection of hepatitis C virus (HCV) RNA detection assays are continuously improving. We aimed to assess the utility of more precise definition of 4th week viral load [rapid virological response (RVR)] in predicting sustaine
Externí odkaz:
https://doaj.org/article/6d5ae9663c7f4ff08ea4506dd003e4c5
Publikováno v:
Italian Journal of Medicine, Vol 9, Iss 1, Pp 82-88 (2015)
Hepatitis C virus (HCV)-related chronic hepatitis is characterized by different clinical outcomes as well as by distinct biochemical and virological patterns. According to guidelines concerning dual therapy, high rates of sustained virological respon
Externí odkaz:
https://doaj.org/article/332d19eff26e4964b39427ab8ca725d4
Autor:
Dong Uk Kim, Gwang Ha Kim, Sung Ik Pyeon, Mong Cho, Sang Gyu Park, Geun Am Song, Hyun Young Woo, Jeong Heo, Young Joo Park, Sung Yong Han, Hyung Hoi Kim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 3, Pp 544-556 (2021)
The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine
Background/Aims: Real-world, clinical practice data are lacking about sofosbuvir/ ribavirin (SOF/RBV) treatment of Korean patients with hepatitis C virus genotype 2 (HCV GT2) infection. This study investigated the efficacy and safety of SOF/RBV in Ko
Autor:
Talha Laique, Jahanzeb Malik, Muhammad Umar Talha, Amina Noor, Sultan Z Khan, Aamna Latif, Bushra Iftikhar
Publikováno v:
Cureus
Background and objective Hepatitis C infection is prevalent in Pakistan. The purpose of this study was to observe the therapeutic effects of conventional interferon in combination with ribavirin among treatment-naive hepatitis C patients. Methods Thi
Autor:
Laura E. Cisneros-Garza
Publikováno v:
Salud Pública de México, Vol 53, Pp S52-S60 (2011)
La hepatitis por virus C constituye un problema de salud importante en México. El diagnóstico de poblaciones de alto riesgo es esencial dada la probabilidad de desarrollar enfermedad crónica, cirrosis, descompensación de la cirrosis y la consecue
Externí odkaz:
https://doaj.org/article/a59fd4269dfc41c2bdf61c7340f0a215
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Gastroenterology, Vol 12, Iss 1, p 167 (2012)
Abstract Background The aim of this study was to evaluate whether polymorphisms in the guanine nucleotide binding (G protein), beta polypeptide 1 (GNB1) gene are associated with a rapid virological response (RVR) among HCV genotype 1 (HCV-1) and 2 (H
Externí odkaz:
https://doaj.org/article/215b772cd4bb45fbb83ad1174f91c6c0
Autor:
Ke-Da Chen, Hai-Ying Yu, Junwei Su, Hangping Yao, Huilin Ou, Da-Zhi Chen, Xiao-Wei Xu, Wu Xiaoxin, Lanjuan Li
Publikováno v:
Medicine
Hepatitis C virus (HCV) is one of the most important virus as the cause of liver disease in China. The aim of the present study was to explore whether sofosbuvir and ribavirin-based treatment can cure patients with chronic hepatitis C in eastern Chin